VIDANEX: Leveraging AI to Detect and Diagnose Cancer

Founded back in November 2023, VIDANEX is the first spin-off company of IMU (also formerly known as International Medical University), with a mission to help digitalise the healthcare space and integrate AI with medical imaging solutions.

From pancreatic to breast cancer and more, this homegrown university spinoff says that its AI-driven insights will empower clinicians to make informed decisions, ultimately improving patient outcomes and ushering in a new era of precision in medicine and patient-centric care.

On top of that, their solution is supposed to help digitalise healthcare by enabling clinicians to transition seamlessly from traditional to modern processes, optimizing efficiency and improving patient care.

All of that sounds inevitably great, but what does it actually mean, look, and feel like in the real world? Well, that is something we will get into, along with the exploration of Dr. Elaine and Daniel's backgrounds, including how they came together to do this.

We also discuss the genesis of their venture and its commercialisation journey, where they are currently on their engagements with the government, and the future aspirations that drive Vidanex.